Asia Vital Components Crecimiento futuro

Future controles de criterios 6/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Asia Vital Components de 28.9% y 17.2% por año respectivamente. Se prevé que el BPA crezca en un 28.5% al año. Se espera que la rentabilidad financiera sea de 33.7% en 3 años.

Información clave

28.3%

Tasa de crecimiento de los beneficios

28.3%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Tech	18.1%
Tasa de crecimiento de los ingresos	21.4%
Rentabilidad financiera futura	33.8%
Cobertura de analistas	Good
Última actualización	07 Jun 2024

Actualizaciones recientes sobre el crecimiento futuro

Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets

Mar 17

Recent updates

Asia Vital Components Co., Ltd.'s (TWSE:3017) P/E Is Still On The Mark Following 30% Share Price Bounce

May 29

Impressive Earnings May Not Tell The Whole Story For Asia Vital Components (TWSE:3017)

Mar 21

Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets

Mar 17

Market Participants Recognise Asia Vital Components Co., Ltd.'s (TWSE:3017) Earnings Pushing Shares 29% Higher

Feb 26

Is Now The Time To Look At Buying Asia Vital Components Co., Ltd. (TPE:3017)?

Apr 23

Does Asia Vital Components (TPE:3017) Have A Healthy Balance Sheet?

Apr 08

Asia Vital Components Co., Ltd.'s (TPE:3017) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?

Mar 21

Will The ROCE Trend At Asia Vital Components (TPE:3017) Continue?

Feb 16

Asia Vital Components Co., Ltd.'s (TPE:3017) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Feb 01

Did You Participate In Any Of Asia Vital Components' (TPE:3017) Fantastic 223% Return ?

Jan 17

Asia Vital Components (TPE:3017) Seems To Use Debt Quite Sensibly

Jan 02

Why Asia Vital Components Co., Ltd. (TPE:3017) Is A Dividend Rockstar

Dec 20

Is Now An Opportune Moment To Examine Asia Vital Components Co., Ltd. (TPE:3017)?

Dec 07

Is There More To The Story Than Asia Vital Components's (TPE:3017) Earnings Growth?

Nov 24

Previsiones de crecimiento de beneficios e ingresos

TWSE:3017 - Estimaciones futuras de los analistas y datos financieros pasados (TWD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	110,867	12,509	11,812	15,812	5
12/31/2025	94,403	10,677	11,155	13,981	9
12/31/2024	71,501	7,467	7,285	10,678	10
3/31/2024	62,669	5,862	9,416	12,594	N/A
12/31/2023	59,194	5,305	6,556	10,324	N/A
9/30/2023	57,251	4,715	4,935	8,918	N/A
6/30/2023	56,365	4,528	3,682	8,120	N/A
3/31/2023	55,258	4,423	4,358	8,612	N/A
12/31/2022	56,017	4,162	5,135	8,840	N/A
9/30/2022	53,452	3,792	3,312	6,298	N/A
6/30/2022	50,342	3,407	2,133	4,482	N/A
3/31/2022	49,327	3,106	1,774	3,727	N/A
12/31/2021	47,333	2,901	1,213	2,841	N/A
9/30/2021	45,646	2,704	2,026	4,261	N/A
6/30/2021	43,922	2,490	2,364	4,768	N/A
3/31/2021	42,778	2,262	1,029	3,626	N/A
12/31/2020	39,666	1,916	2,404	4,870	N/A
9/30/2020	39,361	1,690	2,950	4,833	N/A
6/30/2020	39,228	1,308	1,491	3,318	N/A
3/31/2020	37,107	972	2,185	3,816	N/A
12/31/2019	36,534	958	757	2,458	N/A
9/30/2019	34,258	871	-648	971	N/A
6/30/2019	31,962	800	327	1,905	N/A
3/31/2019	29,482	747	274	1,719	N/A
12/31/2018	29,067	711	-723	971	N/A
9/30/2018	28,673	717	122	1,635	N/A
6/30/2018	27,873	776	-364	940	N/A
3/31/2018	27,178	811	259	1,609	N/A
12/31/2017	27,109	887	N/A	1,806	N/A
9/30/2017	26,750	930	N/A	1,684	N/A
6/30/2017	26,496	898	N/A	1,961	N/A
3/31/2017	26,528	869	N/A	1,230	N/A
12/31/2016	26,504	860	N/A	2,154	N/A
9/30/2016	26,040	826	N/A	3,340	N/A
6/30/2016	26,312	829	N/A	3,133	N/A
3/31/2016	26,194	797	N/A	3,080	N/A
12/31/2015	25,675	741	N/A	2,493	N/A
9/30/2015	25,023	681	N/A	1,124	N/A
6/30/2015	24,317	822	N/A	1,898	N/A
3/31/2015	24,336	820	N/A	2,021	N/A
12/31/2014	24,047	729	N/A	1,962	N/A
9/30/2014	23,739	640	N/A	2,369	N/A
6/30/2014	22,767	355	N/A	913	N/A
3/31/2014	21,397	282	N/A	1,984	N/A
12/31/2013	19,990	246	N/A	1,505	N/A
9/30/2013	18,976	204	N/A	1,119	N/A
6/30/2013	18,415	126	N/A	1,809	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (28.9% al año) de 3017 es superior a la tasa de ahorro (0.8%).

Beneficios vs. Mercado: Se prevé que los beneficios (28.9% al año) de 3017 crezcan más rápidamente que el mercado TW (19.7% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de 3017 crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (17.2% al año) de 3017 crezcan más rápidamente que los del mercado TW (10.6% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos (21.1% al año) de 3017 crezcan más rápidamente que un 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de 3017 sea alta dentro de 3 años (33.7%)

Asia Vital Components Crecimiento futuro

Future controles de criterios 6/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 8.6% to NT$824

Price target increased by 7.8% to NT$759

Price target increased by 7.1% to NT$735

Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets

Price target increased by 8.3% to NT$506

Price target increased by 14% to NT$427

Recent updates

Asia Vital Components Co., Ltd.'s (TWSE:3017) P/E Is Still On The Mark Following 30% Share Price Bounce

Price target increased by 8.6% to NT$824

Investor sentiment improves as stock rises 16%

We Think Asia Vital Components (TWSE:3017) Can Manage Its Debt With Ease

First quarter 2024 earnings: Revenues and EPS in line with analyst expectations

Asia Vital Components Co., Ltd. to Report Q1, 2024 Results on May 10, 2024

Now 20% overvalued after recent price rise

Price target increased by 7.8% to NT$759

Price target increased by 7.1% to NT$735

Do Asia Vital Components' (TWSE:3017) Earnings Warrant Your Attention?

Investor sentiment improves as stock rises 15%

A Look At The Intrinsic Value Of Asia Vital Components Co., Ltd. (TWSE:3017)

Now 20% overvalued after recent price rise

Impressive Earnings May Not Tell The Whole Story For Asia Vital Components (TWSE:3017)

Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets

Asia Vital Components Co., Ltd., Annual General Meeting, Jun 14, 2024

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Now 28% overvalued after recent price rise

Price target increased by 8.3% to NT$506

Investor sentiment improves as stock rises 15%

Market Participants Recognise Asia Vital Components Co., Ltd.'s (TWSE:3017) Earnings Pushing Shares 29% Higher

Now 25% overvalued after recent price rise

Now 26% overvalued after recent price rise

Investor sentiment improves as stock rises 16%

New major risk - Share price stability

Now 24% undervalued after recent price drop

Price target increased by 14% to NT$427

Now 22% undervalued after recent price drop

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improves as stock rises 22%

Upcoming dividend of NT$5.00 per share at 1.5% yield

Investor sentiment improves as stock rises 15%

Asia Vital Components Co., Ltd. Announces Cash Dividend, Payable on September 20, 2023

Second quarter 2023 earnings released: EPS: NT$3.18 (vs NT$3.10 in 2Q 2022)

New major risk - Share price stability

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 18%

First quarter 2023 earnings released: EPS: NT$2.85 (vs NT$2.11 in 1Q 2022)

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 16%

Price target decreased by 13% to NT$108

Full year 2022 earnings released: EPS: NT$11.78 (vs NT$8.21 in FY 2021)

Price target decreased to NT$124

Third quarter 2022 earnings released: EPS: NT$3.51 (vs NT$2.42 in 3Q 2021)

Third quarter 2022 earnings released: EPS: NT$3.51 (vs NT$2.42 in 3Q 2021)

Upcoming dividend of NT$4.30 per share

Second quarter 2022 earnings released: EPS: NT$3.10 (vs NT$2.25 in 2Q 2021)

Asia Vital Components Co., Ltd. Declares Dividend, Payable on September 20, 2022

Investor sentiment improved over the past week

Now 22% undervalued after recent price drop

Asia Vital Components Co., Ltd. Announces Board Changes

Asia Vital Components Co., Ltd. Announces Establishment of the ESG Committee of the Company

Asia Vital Components Co., Ltd. Announces to Shut Down Production Line on Floor

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS NT$2.42 (vs NT$1.81 in 3Q 2020)

Price target increased to NT$102

Investor sentiment improved over the past week

Upcoming dividend of NT$2.80 per share

Second quarter 2021 earnings released: EPS NT$2.25 (vs NT$1.61 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS NT$1.53 (vs NT$0.55 in 1Q 2020)

Investor sentiment deteriorated over the past week

Is Now The Time To Look At Buying Asia Vital Components Co., Ltd. (TPE:3017)?

Does Asia Vital Components (TPE:3017) Have A Healthy Balance Sheet?

Price target increased to NT$84.50

Full year 2020 earnings released: EPS NT$5.42 (vs NT$2.71 in FY 2019)

Asia Vital Components Co., Ltd.'s (TPE:3017) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?